Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a new publication citation (Bagel J et al., 2026) to Publications and updated the page revision to v3.5.0; the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check33 days agoChange DetectedNo user-impacting content changes detected; the study details and sections appear unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' is now displayed at the top of the page. The notice about government funding and the previous 'Revision: v3.4.1' text were removed.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page version updated to v3.4.1 (replacing v3.4.0); no core study content changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedAdded a glossary display option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with Revision set to v3.4.0. The previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.